{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:47:19Z","timestamp":1786981639277,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T00:00:00Z","timestamp":1489190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s11239-017-1490-4","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T01:41:47Z","timestamp":1489196507000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Essential thrombocythemia presenting as acute coronary syndrome: case reports and literature review"],"prefix":"10.1007","volume":"44","author":[{"given":"Nanqing","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,11]]},"reference":[{"key":"1490_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-016-0242-9","volume":"9","author":"A Kaifie","year":"2016","unstructured":"Kaifie A, Kirschner M, Wolf D et al (2016) Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry. J Hematol Oncol 9:18","journal-title":"J Hematol Oncol"},{"issue":"3","key":"1490_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4274\/tjh.2015.0041","volume":"33","author":"And\u0131\u00e7 Neslihan","year":"2016","unstructured":"Neslihan And\u0131\u00e7, Mustafa \u00dcn\u00fcbol, Eren Ya\u011fc\u0131,et al (2016) Clinical features of 294 Turkish patients with chronic myeloproliferative neoplasms. Turk J Hematol 33(3):187\u2013195","journal-title":"Turk J Hematol"},{"issue":"5","key":"1490_CR3","first-page":"396","volume":"19","author":"R Dambrauskiene","year":"2015","unstructured":"Dambrauskiene R, Gerbutavicius R, Juozaityte E et al (2015) Thrombotic risk assessment in 185 WHO-defined essential thrombocythemia patients: single center experience. Contemp Oncol (Pozn) 19(5):396\u2013399","journal-title":"Contemp Oncol (Pozn)"},{"issue":"7","key":"1490_CR4","first-page":"1258","volume":"19","author":"\u00c9 P\u00f3sfai","year":"2015","unstructured":"P\u00f3sfai \u00c9, Marton I, Kotosz B et al (2015) Contribution of cardiovascular risk factors in the thrombotic complications of essential thrombocythaemia: a Hungarian single-institute retrospective analysis. Eur Rev Med Pharmacol Sci 19(7):1258\u20131263","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"1490_CR5","first-page":"397","volume":"16","author":"\u00c9 P\u00f3sfai","year":"2016","unstructured":"P\u00f3sfai \u00c9, Marton I, Borb\u00e9nyi Z et al (2016) Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera. Anatol J Cardiol 16(6):397\u2013402","journal-title":"Anatol J Cardiol"},{"key":"1490_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.11604\/pamj.2014.18.347.5201","volume":"18","author":"NV Yam\u00e9ogo","year":"2014","unstructured":"Yam\u00e9ogo NV, Kagamb\u00e8ga LJ, Yam\u00e9ogo AA, et al (2014) Myocardial infarction indicative of essential thrombocythemia in a young black African patient: report of a case. Pan Afr Med J 18:347","journal-title":"Pan Afr Med J"},{"issue":"19","key":"1490_CR7","first-page":"3512","volume":"127","author":"Z Isilak","year":"2014","unstructured":"Isilak Z, Tezcan M, Atalay M et al (2014) Acute myocardial infarction and sub-acute stent thrombosis associated with occult essential thrombocythemia. Chin Med J (Engl) 127(19):3512\u20133513","journal-title":"Chin Med J (Engl)"},{"key":"1490_CR8","first-page":"123","volume":"5","author":"T Bhat","year":"2014","unstructured":"Bhat T, Ahmed M, Baydoun H et al (2014) Acute ST-segment elevation myocardial infarction in a young patient with essential thrombocythemia: a case with long-term follow-up report. J Blood Med 5:123\u2013127","journal-title":"J Blood Med"},{"issue":"5","key":"1490_CR9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0300-8932(09)71045-0","volume":"62","author":"FJ Camacho","year":"2009","unstructured":"Camacho FJ, Hern\u00e1ndez N, D\u00edaz E et al (2009) Essential thrombocythemia and acute myocardial infarction. Rev Esp Cardiol 62(5):576\u2013588","journal-title":"Rev Esp Cardiol"},{"issue":"3","key":"1490_CR10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08122.x","volume":"149","author":"CN Harrison","year":"2010","unstructured":"Harrison CN, Bareford D, Butt N et al (2010) Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol 149(3):352\u2013375","journal-title":"Br J Haematol"},{"issue":"3","key":"1490_CR11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3324\/haematol.12053","volume":"93","author":"V Stefano De","year":"2008","unstructured":"De Stefano V, Za T, Rossi E et al (2008) Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica 93(3):372\u2013380","journal-title":"Haematologica"},{"issue":"1","key":"1490_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","volume":"353","author":"CN Harrison","year":"2005","unstructured":"Harrison CN, Campbell PJ, Buck G et al (2005) Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 353(1):33\u201345","journal-title":"N Engl J Med"},{"issue":"3","key":"1490_CR13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","volume":"8","author":"S Cortelazzo","year":"1990","unstructured":"Cortelazzo S, Viero P, Finazzi G et al (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8(3):556\u2013562","journal-title":"J Clin Oncol"},{"issue":"2","key":"1490_CR14","first-page":"215","volume":"89","author":"T Barbui","year":"2004","unstructured":"Barbui T, Barosi G, Grossi A et al (2004) Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 89(2):215\u2013232","journal-title":"Haematologica"},{"issue":"5","key":"1490_CR15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1182\/blood-2010-08-270033","volume":"117","author":"PA Beer","year":"2011","unstructured":"Beer PA, Erber WN, Campbell PJ et al (2011) How I treat essential thrombocythemia. Blood 117(5):1472\u20131482","journal-title":"Blood"},{"key":"1490_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13000-015-0269-1","volume":"10","author":"S Rupoli","year":"2015","unstructured":"Rupoli S, Goteri G, Picardi P et al (2015) Thrombosis in essential thrombocytemia and early\/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis. Diagn Pathol 10:29","journal-title":"Diagn Pathol"},{"issue":"4","key":"1490_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/000331970305400414","volume":"54","author":"M Fujimura","year":"2003","unstructured":"Fujimura M, Akaike M, Kato M et al (2003) Aggressive antiplatelet therapy before stenting in acute coronary syndrome with essential thrombocythemia. Angiology 54(4):485\u2013490","journal-title":"Angiology"},{"issue":"3","key":"1490_CR18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jjcc.2009.03.001","volume":"54","author":"N Kumagai","year":"2009","unstructured":"Kumagai N, Mitsutake R, Miura S et al (2009) Acute coronary syndrome associated with essential thrombocythemia. J Cardiol 54(3):485\u2013489","journal-title":"J Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-017-1490-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1490-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1490-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T07:02:41Z","timestamp":1496818961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-017-1490-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,11]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1490"],"URL":"https:\/\/doi.org\/10.1007\/s11239-017-1490-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,11]]}}}